Please login to the form below

Not currently logged in
Email:
Password:

Pfizer/ S-A vaccines halted in Japan

Separate vaccines from sanofi-aventis and Pfizer have had their use suspended in Japan following the deaths of four children

Separate vaccines from sanofi-aventis (S-A) and Pfizer have had their use suspended in Japan following the deaths of four children.

S-A's ActHIB, to protect against Haemophilus influenzae type b, and Pfizer's Prevenar to prevent against pneumococcal disease such as pneumonia and meningitis, have been suspended by Japan's Health Ministry while the causes of deaths of four inoculated children are investigated.

According to the Associated Press, four children, age 2 years old or under, died between March 2 and March 4, with the deaths occurring within a three day period of the vaccines administration.

Over one million children have been inoculated in Japan since ActHIB was launched in the country in December 2008 and Prevenar started to be used in 2009.

The suspension follows a 2009 incident where authorities suspended the use of a batch of Prevenar in the Netherlands after the deaths of three children inoculated with the vaccine.

Authorities later decided there was no correlation between the deaths and the vaccinations.

7th March 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...
Emotional Intelligence and Blended Learning in Healthcare
EI and emotional selling are rising up the agenda when it comes to healthcare training. This article outlines how blended learning approaches can help put them into action....

Infographics